We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Rubella IgG Assay Launched

By HospiMedica staff writers
Posted on 26 Mar 2007
An assay has been launched that aids in the determination of immunity to rubella infection, commonly known as German measles.

The Vitros Rubella IgG assay1 determines if IgG antibodies to the rubella virus are in the blood. More...
The presence of IgG antibodies may indicate a recent or past rubella infection or that a rubella vaccine has been given and is providing adequate protection. The Vitros ECi/ECiQ immunodiagnostic system is a simple-to-use, flexible, and fully-automated
laboratory testing system that provides true continuous STAT, random access capabilities for routine and specialty immunodiagnostic testing. The system uses proprietary enhanced chemiluminescence detection.

Rubella is a viral infection that manifests itself as a mild rash on the skin and a low-grade fever. It is primarily transmitted via droplets from the nose or throat that others inhale. It is also transmitted from a pregnant woman's bloodstream to the unborn child. It is generally a mild disease in children and healthy adults. However, there can be significant medical danger if a pregnant woman has an active infection and the developing unborn child becomes infected. This can lead to death of the unborn child or birth defects such as blindness, deafness, metal retardation, and cardiac abnormalities. The risk of fetal infection and the severity of defects are greatest during the first trimester.

Ortho-Clinical Diagnostics (Raritan, NJ, USA), a Johnson & Johnson company, announced U.S. Food and Drug Administration (FDA) clearance and availability of the Vitros rubella IgG assay1. The Vitros ECi/ECiQ immunodiagnostic system uses Intellicheck technology, a technology designed to verify diagnostic checks throughout automated sample and assay processing. Intellicheck serves to increase the integrity and security of reported patient results while helping to ensure greater confidence and productivity for laboratories that generate these results.

"Even though the incidence of rubella infections [is at a] record low, routine rubella IgG testing is a vital part of pre-natal screening to determine the immune status of females planning pregnancy” said Michael Waller, M.D., vice president, clinical and medical affairs for Ortho-Clinical Diagnostics. "Once the results are known, appropriate vaccination or precautions can be made.”


Related Links:
Ortho-Clinical Diagnostics

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical Examination & Procedure Light
Vega 80
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.